01 8AbbVie Inc
02 4Amneal Pharmaceuticals
03 4Aurobindo Pharma Limited
04 4Hikma Pharmaceuticals
05 4Prinston
06 1Unichem Laboratories Limited
01 4CAPSULE (EXTENDED RELEASE)
02 20CAPSULE, EXTENDED RELEASE;ORAL
03 1Tablet
01 12DISCN
02 1Generic
03 4Prescription
04 8RX
01 8FETZIMA
02 16LEVOMILNACIPRAN HYDROCHLORIDE
03 1Blank
01 4Canada
02 1India
03 20USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FETZIMA
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 20MG BASE
Packaging :
Approval Date : 2013-07-25
Application Number : 204168
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FETZIMA
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 40MG BASE
Packaging :
Approval Date : 2013-07-25
Application Number : 204168
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FETZIMA
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 80MG BASE
Packaging :
Approval Date : 2013-07-25
Application Number : 204168
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : FETZIMA
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 120MG BASE
Packaging :
Approval Date : 2013-07-25
Application Number : 204168
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Prescription
Registration Country : Canada
LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE)
Brand Name : FETZIMA
Dosage Form : CAPSULE (EXTENDED RELEASE)
Dosage Strength : 40MG
Packaging :
Approval Date :
Application Number : 2440989
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE)
Brand Name : FETZIMA
Dosage Form : CAPSULE (EXTENDED RELEASE)
Dosage Strength : 80MG
Packaging :
Approval Date :
Application Number : 2440997
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE)
Brand Name : FETZIMA
Dosage Form : CAPSULE (EXTENDED RELEASE)
Dosage Strength : 20MG
Packaging :
Approval Date :
Application Number : 2440970
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
LEVOMILNACIPRAN (LEVOMILNACIPRAN HYDROCHLORIDE)
Brand Name : FETZIMA
Dosage Form : CAPSULE (EXTENDED RELEASE)
Dosage Strength : 120MG
Packaging :
Approval Date :
Application Number : 2441004
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LEVOMILNACIPRAN HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 20MG BASE
Packaging :
Approval Date : 2019-02-04
Application Number : 210790
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LEVOMILNACIPRAN HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 40MG BASE
Packaging :
Approval Date : 2019-02-04
Application Number : 210790
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LEVOMILNACIPRAN HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 80MG BASE
Packaging :
Approval Date : 2019-02-04
Application Number : 210790
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LEVOMILNACIPRAN HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 120MG BASE
Packaging :
Approval Date : 2019-02-04
Application Number : 210790
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LEVOMILNACIPRAN HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 20MG BASE
Packaging :
Approval Date : 2020-11-05
Application Number : 210732
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LEVOMILNACIPRAN HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 40MG BASE
Packaging :
Approval Date : 2020-11-05
Application Number : 210732
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LEVOMILNACIPRAN HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 80MG BASE
Packaging :
Approval Date : 2020-11-05
Application Number : 210732
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : LEVOMILNACIPRAN HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 120MG BASE
Packaging :
Approval Date : 2020-11-05
Application Number : 210732
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LEVOMILNACIPRAN HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 20MG BASE
Packaging :
Approval Date : 2023-03-20
Application Number : 210771
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LEVOMILNACIPRAN HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 40MG BASE
Packaging :
Approval Date : 2023-03-20
Application Number : 210771
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LEVOMILNACIPRAN HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 80MG BASE
Packaging :
Approval Date : 2023-03-20
Application Number : 210771
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LEVOMILNACIPRAN HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 120MG BASE
Packaging :
Approval Date : 2023-03-20
Application Number : 210771
Regulatory Info : RX
Registration Country : USA
LOOKING FOR A SUPPLIER?